The revenue of AbbVie Inc. over the past 10 years
Chart AbbVie Inc.: revenue, fiscal 2016–2025 Open the chart →AbbVie Inc. reported revenue of $61.16B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $25.64B — up 139% over 9 years. Year over year, revenue rose 8 times and fell once. The largest one-year move was in fiscal 2020: up 38%, from $33.27B to $45.8B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $61.16B |
| 2024ended Dec 31, 2024 | $56.33B |
| 2023ended Dec 31, 2023 | $54.32B |
| 2022ended Dec 31, 2022 | $58.05B |
| 2021ended Dec 31, 2021 | $56.2B |
| 2020ended Dec 31, 2020 | $45.8B |
| 2019ended Dec 31, 2019 | $33.27B |
| 2018ended Dec 31, 2018 | $32.75B |
| 2017ended Dec 31, 2017 | $28.22B |
| 2016ended Dec 31, 2016 | $25.64B |
Fiscal years as AbbVie Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AbbVie Inc.
- The profitability of AbbVie Inc.
- The cash flow of AbbVie Inc.
- The debt of AbbVie Inc.
- The dividends of AbbVie Inc.
- All of AbbVie Inc.'s financials, charted
Companies of a similar size
- MAMastercard Incorporated
- PLTRPalantir Technologies Inc.
- ONCBEONE MEDICINES LTD.
- PDDPDD Holdings Inc.
- JNJJohnson & Johnson
Not investment advice. This page shows what AbbVie Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.